Last reviewed · How we verify
NCT05704751: ECAP
EVOKE ECAP-Controlled Lead Placement and Programming in Chronic Pain Patients
trial testing spinal cord stimulation in Back Pain Lower Back Chronic in 20 participants. Currently enrolling.
1 March 2026
Quick facts
| Lead sponsor | Barts & The London NHS Trust |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 27 October 2023 |
| Primary completion | 1 March 2026 |
| Estimated completion | 1 April 2026 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- spinal cord stimulation
Conditions studied
- Back Pain Lower Back Chronic — all drugs for Back Pain Lower Back Chronic →
- Spinal Cord Stimulation — all drugs for Spinal Cord Stimulation →
Sponsor
Barts & The London NHS Trust — full company profile →
Who can join
Adults 18 to 75, any sex, with Back Pain Lower Back Chronic or Spinal Cord Stimulation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is designed to evaluate the feasibility of using intra-operative ECAP and Late-Response (LR) recordings for confirmation of activating the neuronal target of the dorsal column in a single-stage SCS lead placement procedure. The collected ECAP and LR data will be analysed post-hoc to further evaluate its utility for determining the laterality of lead placement with respect to the physiologic midline of the dorsal column.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05704751
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of spinal cord stimulation
Trials testing the same drug.
- NCT04010838 — Spinal Cord Stimulation in Patients With Disorders of Consciousness · NA · unknown
Other recruiting trials for Back Pain Lower Back Chronic
Currently open trials in the same condition.
- NCT07334288 — Retrolaminar Analgesia for LuMbar Surgery · NA · recruiting
- NCT06825390 — AuriculoTherapy NeuroImaging · NA · recruiting
- NCT06476392 — Melatonin fOr CHronic bAck Pain (The MOCHA Trial) · Phase 3 · active not recruiting
- NCT05851196 — The Forgotten Role of Back Muscle Characteristics to Tailor Exercise Therapy for Recurrent Non-specific Low Back Pain · recruiting
- NCT05953155 — YOga for Patients with Chronic BACK Pain and Poor PROgnosis · NA · recruiting
Other Barts & The London NHS Trust trials
Trials by the same sponsor.
- NCT05753085 — Multimodality Optical and Ultrasound Intravascular Imaging for Stent Optimization and Atheroma Assessment · NA · withdrawn
- NCT07047235 — Substrate Remodelling and Targeted Ablation in AF · NA · recruiting
- NCT06871215 — Inflammation and Infective Endocarditis · withdrawn
- NCT07076524 — MuScle WastIng and DysphaGia iN CriticAlly IlL Patients (SIGNAL) · recruiting
- NCT06596486 — A Comparison of CoolStick With Ethyl Chloride for the Assessment of Light Touch · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05704751 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Barts & The London NHS Trust
- Last refreshed: 8 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05704751.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing